Physician profile
Allison Groff
NPI 1346568557
$1,651.86
in general payments reported to CMS, 2019-2025
27 companies · $260 in 2025
The $260 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.63 · 2020: $69.02 · 2021: $221 · 2022: $266 · 2023: $488 · 2024: $317 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,051 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,051.27 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $195.73 | 2020-2025 | Orilissa, Lo Loestrin Fe |
| Intuitive Surgical, INC. | $184.52 | 2023-2025 | Da Vinci Surgical System |
| Baxter Healthcare | $143.85 | 2023 | Tisseel |
| Astellas Pharma US INC | $133.51 | 2024-2025 | Veozah |
| Therapeuticsmd, INC. | $125.37 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $120.03 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $111.36 | 2022-2024 | |
| Aspira Women'S Health INC | $89.82 | 2022-2024 | Ova1 |
| Millicent US INC | $72.39 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Coopersurgical, INC. | $52.03 | 2021 | |
| Sage Therapeutics, LLC | $48.10 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $41.08 | 2023-2024 | Injectafer |
| Sumitomo Pharma America, INC. | $38.07 | 2023-2025 | Gemtesa, Myfembree |
| Myovant Sciences INC. | $36.00 | 2021-2022 | |
| Exeltis, USA INC. | $34.74 | 2024 | Slynd |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $25.05 | 2024 | |
| Radius Health, INC. | $24.70 | 2023 | Tymlos |
| Evofem Biosciences, INC. | $23.24 | 2020-2022 | |
| Alydia Health | $20.79 | 2021 | |
| Organon LLC | $18.47 | 2024 | |
| Amag Pharmaceuticals, INC. | $18.20 | 2019 | |
| Allergan, INC. | $17.54 | 2020 | |
| Mylan Pharmaceuticals INC. | $16.90 | 2021 | |
| Boston Scientific Corporation | $15.49 | 2023 | Spaceoar Vue System - 10ml |
| Avion Pharmaceuticals | $15.31 | 2021 | |
| Distalmotion US | $15.07 | 2025 | Dexter L6 Robot |
| Ethicon US, LLC | $14.50 | 2023 | Stratafix, Vistaseal, Dermabond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Groff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.